A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation
Clinical trial NCT07060989 · RECRUITING
Trial details
- NCT number
- NCT07060989
- Sponsor
- Nutshell Therapeutics (Shanghai) Co., LTD.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-04
- Primary completion
- 2028-12-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.